A phase I study to determine the pharmacokinetics and urinary excretion of belinostat and metabolites in patients with advanced solid tumors

被引：0
|
作者：
Hanna Bailey
Jordan P. McPherson
Erin B. Bailey
Theresa L. Werner
Sumati Gupta
Julia Batten
Guru Reddy
Gajanan Bhat
Sunil Sharma
Neeraj Agarwal
机构：
[1] The University of Utah,Huntsman Cancer Institute
[2] Spectrum Pharmaceuticals,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2016年 / 78卷
关键词：
Belinostat; PXD101; HDAC inhibitor; Pharmacokinetics; Metabolites; Elimination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1059 / 1071
页数：12
相关论文
共 50 条
  • [41] A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors
    Tufia Haddad
    Rui Qin
    Ruth Lupu
    Daniel Satele
    Matthew Eadens
    Matthew P. Goetz
    Charles Erlichman
    Julian Molina
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 1221 - 1227
  • [42] A phase I study of the ceramide nanoliposome in patients with advanced solid tumors
    Ciner, Aaron
    Gourdin, Theodore
    Davidson, Jeff
    Parette, Mylisa
    Walker, Susan J.
    Fox, Todd E.
    Jiang, Yixing
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 93 (01) : 23 - 29
  • [43] Phase I study of olaratumab in Japanese patients with advanced solid tumors
    Doi, Toshihiko
    Ma, Yan
    Dontabhaktuni, Aruna
    Nippgen, Cornelia
    Nippgen, Johannes
    Ohtsu, Atsushi
    CANCER SCIENCE, 2014, 105 (07) : 862 - 869
  • [44] A phase I study of resminostat in Japanese patients with advanced solid tumors
    Satoru Kitazono
    Yutaka Fujiwara
    Shinji Nakamichi
    Hidenori Mizugaki
    Hiroshi Nokihara
    Noboru Yamamoto
    Yasuhide Yamada
    Eri Inukai
    Osamu Nakamura
    Tomohide Tamura
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 1155 - 1161
  • [45] Phase I study of docetaxel and ifosfamide in patients with advanced solid tumors
    Pronk, L
    Shrijvers, D
    LocciTonelli, D
    Verweij, J
    VanOosterom, AT
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 961 - 961
  • [46] Phase I study of piritrexim and gemcitabine in patients with advanced solid tumors
    Huie, M
    Carducci, M
    Liu, G
    Wilding, GG
    Marnocha, R
    Izquierda, M
    Thomas, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (06): : 613 - 617
  • [47] Phase I study on docetaxel and Gemcitabine in patients with advanced solid tumors
    Jaremtchuk, AV
    Zarba, JJ
    Ferro, A
    ANNALS OF ONCOLOGY, 1998, 9 : 138 - 139
  • [48] A phase i study of ixazomib and erlotinib in patients with advanced solid tumors
    Shumei Kato
    Jacob J. Adashek
    Vivek Subbiah
    Siqing Fu
    Mianen Sun
    Ly Nguyen
    Elsa J. Brown
    Timothy A. Yap
    Daniel D. Karp
    Sarina A. Piha-Paul
    David S. Hong
    Investigational New Drugs, 2022, 40 : 99 - 105
  • [49] A phase I study of the ceramide nanoliposome in patients with advanced solid tumors
    Aaron Ciner
    Theodore Gourdin
    Jeff Davidson
    Mylisa Parette
    Susan J. Walker
    Todd E. Fox
    Yixing Jiang
    Cancer Chemotherapy and Pharmacology, 2024, 93 : 23 - 29
  • [50] A phase I study of bortezomib and temozolomide in patients with advanced solid tumors
    J. Portnow
    P. Frankel
    S. Koehler
    P. Twardowski
    S. Shibata
    C. Martel
    R. Morgan
    M. Cristea
    W. Chow
    D. Lim
    V. Chung
    K. Reckamp
    L. Leong
    T. W. Synold
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 505 - 514
12345